1) Adityanjee, Schulz SC:Clinical use of quetiapine in disease states other than schizophrenia. J Clin Psychiatry 63(Suppl 13):32-38, 2002
2) Amann BL, Pogarell O, Mergl R, et al:EEG abnormalities associated with antipsychotics a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Hum Psychopharmacol 18:641-646, 2003
3) Centorrino F, Price B, Tuttle M, et al:EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry 159:109-115, 2002
4) Collaborative Working Group on Clinical Trial Evaluations:Adverse effects of the atypical antipsychosis. J Clin Psychiatry 59(Suppl 12):17-22, 1998
5) Dev V, Raniwalla J:Quetiapine. A review of its safety in the management of schizophrenia. Drug Safety 23:295-307, 2000
6) Dogu O, Sevim S, Kaleagasi HS:Seizure associated with quetiapine treatment. Ann Pharmacother 37:1224-1227, 2003
7) Fujikawa T, Takahashi T, Kinoshita A, et al:Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type. Neuropsychobiology 49:201-204, 2004
8) Hedges DW, Jeppson KG:New-onset seizure associated with quetiapine and olanzapine. Ann Pharmacother 36:437-439, 2002
9) Martin A, Koenig K, Scahill L, et al:Open-label quetiapine in the treatment of children and adolescents with autistic disorder. J Child Adolesc Psychopharmacol 9:99-107, 1999
10) Pisani F, Oteri G, Costa C, et al:Effects of psychotropic drugs on seizure threshold. Drug Saf 25:91-110, 2002
11) Ripple MG, Pestaner JP, Levine BS, et al:Lethal combination of tramadol and multiple drugs affecting serotonin. Am J Forensic Med Pathol 21:370-374, 2000